Literature DB >> 32879513

Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.

Emma S Winkler1,2, Adam L Bailey2, Natasha M Kafai1,2, Sharmila Nair1, Broc T McCune1, Jinsheng Yu3, Julie M Fox1, Rita E Chen1,2, James T Earnest1, Shamus P Keeler1,4, Jon H Ritter2, Liang-I Kang2, Sarah Dort5, Annette Robichaud5, Richard Head3, Michael J Holtzman1,4, Michael S Diamond6,7,8,9.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID： 32879513      PMCID： PMC7464056          DOI： 10.1038/s41590-020-0794-2

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


  13 in total

1.  Animal Models of COVID-19: Transgenic Mouse Model.

Authors:  Jun-Gyu Park; Paula A Pino; Anwari Akhter; Xavier Alvarez; Jordi B Torrelles; Luis Martinez-Sobrido
Journal:  Methods Mol Biol       Date:  2022

2.  Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model.

Authors:  Brittany Seibert; C Joaquín Cáceres; Stivalis Cardenas-Garcia; Silvia Carnaccini; Ginger Geiger; Daniela S Rajao; Elizabeth Ottesen; Daniel R Perez
Journal:  Microbiol Spectr       Date:  2021-08-11

3.  A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids.

Authors:  Jan Wysocki; Minghao Ye; Luise Hassler; Ashwani Kumar Gupta; Yuguo Wang; Vlad Nicoleascu; Glenn Randall; Jason A Wertheim; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2021-02-01       Impact factor: 14.978

4.  Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection.

Authors:  Jennifer S Chen; Mia Madel Alfajaro; Ryan D Chow; Jin Wei; Renata B Filler; Stephanie C Eisenbarth; Craig B Wilen
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

5.  IL-13 is a driver of COVID-19 severity.

Authors:  Alexandra N Donlan; Tara E Sutherland; Chelsea Marie; Saskia Preissner; Ben T Bradley; Rebecca M Carpenter; Jeffrey M Sturek; Jennie Z Ma; G Brett Moreau; Jeffrey R Donowitz; Gregory A Buck; Myrna G Serrano; Stacey L Burgess; Mayuresh M Abhyankar; Cameron Mura; Philip E Bourne; Robert Preissner; Mary K Young; Genevieve R Lyons; Johanna J Loomba; Sarah J Ratcliffe; Melinda D Poulter; Amy J Mathers; Anthony Day; Barbara J Mann; Judith E Allen; William A Petri
Journal:  medRxiv       Date:  2021-03-01

6.  Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.

Authors:  Gema M Olivarria; Yuting Cheng; Susana Furman; Collin Pachow; Lindsay A Hohsfield; Charlene Smith-Geater; Ricardo Miramontes; Jie Wu; Mara S Burns; Kate I Tsourmas; Jennifer Stocksdale; Cynthia Manlapaz; William H Yong; John Teijaro; Robert Edwards; Kim N Green; Leslie M Thompson; Thomas E Lane
Journal:  bioRxiv       Date:  2021-11-17

Review 7.  Experimental Models of COVID-19.

Authors:  Luis A Caldera-Crespo; Michael J Paidas; Sabita Roy; Carl I Schulman; Norma Sue Kenyon; Sylvia Daunert; Arumugam R Jayakumar
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

8.  Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.

Authors:  Gema M Olivarria; Yuting Cheng; Susana Furman; Collin Pachow; Lindsay A Hohsfield; Charlene Smith-Geater; Ricardo Miramontes; Jie Wu; Mara S Burns; Kate I Tsourmas; Jennifer Stocksdale; Cynthia Manlapaz; William H Yong; John Teijaro; Robert Edwards; Kim N Green; Leslie M Thompson; Thomas E Lane
Journal:  J Virol       Date:  2021-12-22       Impact factor: 5.103

9.  The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.

Authors:  Kun Li; David K Meyerholz; Jennifer A Bartlett; Paul B McCray
Journal:  mBio       Date:  2021-08-03       Impact factor: 7.867

10.  IL-13 is a driver of COVID-19 severity.

Authors:  Alexandra N Donlan; Tara E Sutherland; Chelsea Marie; Saskia Preissner; Benjamin T Bradley; Rebecca M Carpenter; Jeffrey M Sturek; Jennie Z Ma; G Brett Moreau; Jeffrey R Donowitz; Gregory A Buck; Myrna G Serrano; Stacey L Burgess; Mayuresh M Abhyankar; Cameron Mura; Philip E Bourne; Robert Preissner; Mary K Young; Genevieve R Lyons; Johanna J Loomba; Sarah J Ratcliffe; Melinda D Poulter; Amy J Mathers; Anthony J Day; Barbara J Mann; Judith E Allen; William A Petri
Journal:  JCI Insight       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.